HealthWarehouse.com Inc. returned to profitability in 2025 due to a 46% revenue increase driven by robust B2B prescription sales, particularly GLP-1 medications. However, changes in the GLP-1 market are expected to impact results negatively in 2026, emphasizing the need for content creators to monitor shifts in pharmaceutical markets and business models.
Read the full article at Digital Commerce 360
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.





